Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akanda Corp. stock logo
AKAN
Akanda
$3.45
-2.5%
$3.96
$2.91
$8.75
$1.62M1.61165,754 shs20,733 shs
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
$4.51
+3.7%
$11.94
$4.20
$28.60
$3.06M1.4677,263 shs234,531 shs
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
$1.02
-4.7%
$1.05
$0.55
$1,200.00
$6.41MN/A477,431 shs175,755 shs
Nuvilex Inc. stock logo
PMCB
Nuvilex
$0.96
+2.6%
$1.00
$0.80
$2.42
$6.35M-0.24118,320 shs7,296 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akanda Corp. stock logo
AKAN
Akanda
-2.54%-5.74%+3.18%-18.82%-52.82%
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
+3.68%-51.24%-49.89%-32.89%-38.89%
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
-4.67%-6.42%-11.30%+26.87%+101,999,900.00%
Nuvilex Inc. stock logo
PMCB
Nuvilex
+2.59%+2.02%+12.71%-6.08%-36.56%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akanda Corp. stock logo
AKAN
Akanda
$3.45
-2.5%
$3.96
$2.91
$8.75
$1.62M1.61165,754 shs20,733 shs
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
$4.51
+3.7%
$11.94
$4.20
$28.60
$3.06M1.4677,263 shs234,531 shs
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
$1.02
-4.7%
$1.05
$0.55
$1,200.00
$6.41MN/A477,431 shs175,755 shs
Nuvilex Inc. stock logo
PMCB
Nuvilex
$0.96
+2.6%
$1.00
$0.80
$2.42
$6.35M-0.24118,320 shs7,296 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akanda Corp. stock logo
AKAN
Akanda
-2.54%-5.74%+3.18%-18.82%-52.82%
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
+3.68%-51.24%-49.89%-32.89%-38.89%
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
-4.67%-6.42%-11.30%+26.87%+101,999,900.00%
Nuvilex Inc. stock logo
PMCB
Nuvilex
+2.59%+2.02%+12.71%-6.08%-36.56%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Akanda Corp. stock logo
AKAN
Akanda
0.00
N/AN/AN/A
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
3.60
Strong Buy$24.00432.15% Upside
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
0.00
N/AN/AN/A
Nuvilex Inc. stock logo
PMCB
Nuvilex
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest AKAN, PMCB, PLRZ, and ARTL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/26/2025
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$18.00
8/18/2025
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$18.00
8/4/2025
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$20.00 ➝ $18.00
7/8/2025
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
D Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldStrong-Buy
7/8/2025
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldBuy$20.00
6/11/2025
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
D Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
6/6/2025
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$36.00
(Data available from 9/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Akanda Corp. stock logo
AKAN
Akanda
$840K1.89N/AN/A$9.37 per share0.37
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
N/AN/AN/AN/A$5.31 per shareN/A
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
N/AN/AN/AN/A$315.05 per shareN/A
Nuvilex Inc. stock logo
PMCB
Nuvilex
N/AN/AN/AN/A$7.56 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Akanda Corp. stock logo
AKAN
Akanda
-$4.10MN/A0.00N/AN/AN/AN/AN/A
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
-$9.83M-$19.05N/AN/AN/AN/A-497.68%-213.76%11/10/2025 (Estimated)
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
-$1.54MN/A0.00N/AN/AN/AN/AN/A
Nuvilex Inc. stock logo
PMCB
Nuvilex
$30.66M$2.590.37N/AN/A4.60%3.76%9/15/2025 (Estimated)

Latest AKAN, PMCB, PLRZ, and ARTL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
-$0.13-$5.61-$5.48-$5.61N/AN/A
8/8/2025Q4 2025
Nuvilex Inc. stock logo
PMCB
Nuvilex
N/A-$0.25N/A-$2.02N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Akanda Corp. stock logo
AKAN
Akanda
N/AN/AN/AN/AN/A
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
N/AN/AN/AN/AN/A
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
N/AN/AN/AN/AN/A
Nuvilex Inc. stock logo
PMCB
Nuvilex
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Akanda Corp. stock logo
AKAN
Akanda
N/A
1.39
1.39
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
N/A
0.39
0.39
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
N/A
10.16
10.16
Nuvilex Inc. stock logo
PMCB
Nuvilex
N/A
7.68
7.68

Institutional Ownership

CompanyInstitutional Ownership
Akanda Corp. stock logo
AKAN
Akanda
1.00%
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
0.87%
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
N/A
Nuvilex Inc. stock logo
PMCB
Nuvilex
34.24%

Insider Ownership

CompanyInsider Ownership
Akanda Corp. stock logo
AKAN
Akanda
20.39%
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
5.80%
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
N/A
Nuvilex Inc. stock logo
PMCB
Nuvilex
10.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Akanda Corp. stock logo
AKAN
Akanda
110460,000364,000Not Optionable
Artelo Biosciences, Inc. stock logo
ARTL
Artelo Biosciences
5700,000663,000Not Optionable
Polyrizon Ltd. stock logo
PLRZ
Polyrizon
N/A5.99 millionN/AN/A
Nuvilex Inc. stock logo
PMCB
Nuvilex
46.80 million6.10 millionOptionable

Recent News About These Companies

MyMD Pharmaceuticals Secures Strategic Investments
PharmaCyte Biotech Inc PMCB
PharmaCyte Biotech Invests In Femasys - Quick Facts
Los Angeles Biotech News
Biotech ETFs’ Performance Deserves A Look

New MarketBeat Followers Over Time

Media Sentiment Over Time

Akanda stock logo

Akanda NASDAQ:AKAN

$3.45 -0.09 (-2.54%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$3.44 -0.01 (-0.29%)
As of 09/5/2025 06:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Artelo Biosciences stock logo

Artelo Biosciences NASDAQ:ARTL

$4.51 +0.16 (+3.68%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$4.56 +0.04 (+1.00%)
As of 09/5/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. It's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, post-traumatic stress disorder, epilepsy, inflammatory bowel disease, and other potential indications; and ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Polyrizon stock logo

Polyrizon NASDAQ:PLRZ

$1.02 -0.05 (-4.67%)
As of 09/5/2025 04:00 PM Eastern

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

Nuvilex stock logo

Nuvilex NASDAQ:PMCB

$0.96 +0.02 (+2.59%)
Closing price 09/5/2025 03:59 PM Eastern
Extended Trading
$0.97 +0.01 (+1.46%)
As of 09/5/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PharmaCyte Biotech, Inc., a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. The company develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; and license agreements with SG Austria Pte. Ltd. and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.